• Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Analysts

    来源: Buzz FX / 05 10月 2024 02:06:12   America/New_York


    Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc.
    Read more...
分享